Planet Labs PBC PL
17.43
(0.19)
(1.08%)
as of 25 Sep
- Market cap
- $6.6B
- P/E
- 0.0×
Follow PL
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
19.47 | 38.06 | 22.86 | 14.73 | |
P/FCF ratio |
370.60 | 301.66 | 133.04 | 115.14 | |
P/Operating CF |
139.09 | 827.33 | 340.61 | 145.47 | |
P/B ratio |
13.05 | 28.79 | 37.33 | 11.90 | |
Price to Tangible BV |
18.73 | 46.38 | 383.36 | 22.48 | |
EV/Sales |
18.38 | 37.24 | 22.25 | 13.93 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
59.11 | 94.36 | 50.96 | 36.64 | |
EV/FCF |
349.92 | 295.14 | 129.53 | 108.94 | |
Quick Ratio |
2.64 | 2.62 | 1.54 | 3.84 | |
Current Ratio |
2.84 | 2.81 | 1.65 | 4.00 | |
Net Debt/EBITDA |
154.01 | 11.99 | 7.52 | 27.52 | |
Debt/Assets |
31.33% | 35.76% | 39.01% | 40.34% | |
Debt/Equity |
0.79 | 1.01 | 2.37 | 1.28 | |
Asset Turnover |
0.36 | 0.35 | 0.35 | 0.33 | |
Operating CF/Net income |
(5.66) | (0.11) | (0.14) | (0.48) | |
Capex/Depreciation |
(2.70) | (1.60) | (2.25) | (2.79) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
30.29% | 35.50% | 37.08% | 33.63% | |
Selling, General and Administrative Expense of Revenue |
37.90% | 55.09% | 58.56% | 46.27% | |
Intangible Assets out of Total Assets |
0.12 | 0.13 | 0.15 | 0.15 | |
Share Based Compensation of Revenue |
14.70% | 17.48% | 17.88% | 16.58% | |
Graham Net Nets |
0.02 | 0.00 | (0.03) | 0.00 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(5.37%) | (3.08%) | (3.41%) | (3.12%) | |
Free Cash Flow Yield |
0.27% | 0.33% | 0.75% | 0.87% | |
Revenue per Share |
0.32 | 0.27 | 0.28 | 0.26 | |
Operating CF per Share |
0.15 | 0.04 | 0.07 | 0.09 | |
Capex per Share |
(0.08) | (0.05) | (0.07) | (0.09) | |
Free Cash Flow per Share |
0.07 | (0.01) | (0.01) | 0.00 | |
Cash per Share |
2.41 | 2.12 | 2.08 | 2.19 | |
Shareholders Equity per Share |
1.57 | 1.28 | 0.61 | 1.13 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.57 | 1.28 | 0.61 | 1.13 | |
Free Cash Flow |
23.81 | (2.52) | (2.34) | 0.91 | |
Working Capital |
647.52 | 546.43 | 305.91 | 565.55 | |
Capital Expenditures |
(29.13) | (17.96) | (22.98) | (27.68) | |
Net Current Asset Value |
132.18 | 41.25 | (181.89) | (2.36) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.25 | 0.19 | 0.26 | 0.34 | |
Net Profit Margin |
(8.06%) | (147.50%) | (175.59%) | (72.84%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
55.75 | 68.13 | 69.68 | 42.59 | |
Average Payables |
10.70 | 6.57 | 6.61 | 3.51 | |
Average Assets |
1,063.69 | 954.91 | 889.74 | 868.41 | |
Average Common Equity |
500.02 | 444.25 | 314.86 | 407.08 |
Columns are period end dates